HORMONE-REFRACTORY PROSTATE CANCER-NEW OPTIONS FOR ITS MANAGEMENT

被引:0
|
作者
Holubec, L.
Klecka, J.
Topolcan, O.
Pesta, M.
Eret, V.
Finek, J.
Hora, M.
机构
[1] Fac Hosp, Plzen 30599, Czech Republic
[2] Med Sch Pilsen, Plzen 30599, Czech Republic
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
277
引用
收藏
页码:3319 / 3319
页数:1
相关论文
共 50 条
  • [41] The role of bisphosphonates in hormone-refractory prostate cancer
    Fred Saad
    Pierre Karakiewicz
    Paul Perrotte
    [J]. World Journal of Urology, 2005, 23 : 14 - 18
  • [42] Satraplatin in the treatment of hormone-refractory prostate cancer
    Sternberg, CN
    [J]. BJU INTERNATIONAL, 2005, 96 (07) : 990 - 994
  • [43] Hormone-refractory prostate cancer: Therapeutic approach
    Pepe, A.
    Leonardi, V.
    Palmisano, V.
    Savio, G.
    Calabria, C.
    Laudani, A.
    Usset, A.
    Cusimano, M.
    Agostara, B.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 154 - 155
  • [44] Cabazitaxel: A Guide to Its Use in Hormone-Refractory Metastatic Prostate Cancer
    Keating, Gillian M.
    [J]. DRUGS & AGING, 2013, 30 (05) : 359 - 365
  • [45] Pyrazoloacridine for the treatment of hormone-refractory prostate cancer
    Small, EJ
    Fippin, LJ
    Whisenant, SP
    [J]. CANCER INVESTIGATION, 1998, 16 (07) : 456 - 461
  • [46] Combination therapy in hormone-refractory prostate cancer
    Daniel P. Petrylak
    [J]. Current Oncology Reports, 2001, 3 (5) : 453 - 453
  • [47] Treatment options for hormone-refractory prostate cancer [Therapieoptionen des hormonrefraktären prostatakarzinoms]
    Heidenreich A.
    Ohlmann C.H.
    [J]. Der Urologe, 2005, 44 (11): : 1303 - 1314
  • [48] Chemotherapy for the treatment of hormone-refractory prostate cancer
    Petrylak, DP
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 15 - 23
  • [49] Hormone-refractory prostate cancer responding to bevacizumab
    Iacobelli, Stefano
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (08) : 754 - 754
  • [50] The continuing challenge of hormone-refractory prostate cancer
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2006, 4 (04) : 238 - 239